Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide
2. Hms5552
3. Sinogliatin
1. 1191995-00-2
2. Hms5552
3. Sinogliatin
4. Ro5305552
5. Hms-5552
6. Dorzagliatin [inn]
7. Ro-5305552
8. X59w6980e8
9. Dorzagliatin (usan)
10. Dorzagliatin [usan]
11. (2s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide
12. (2s)-2-[4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl]-n-{1-[(2r)-2,3-dihydroxypropyl]-1h-pyrazol-3-yl}-4-methylpentanamide
13. Dorzagliatin [usan:inn]
14. Dorzagliatin [who-dd]
15. Schembl1079619
16. Chembl4297508
17. Unii-x59w6980e8
18. Gtpl12124
19. Hms5552hms5552
20. Glxc-25388
21. Bcp20539
22. Ex-a4478
23. Mfcd22376579
24. S6921
25. Hms5552;ro5305552;sinogliatin
26. Db15123
27. Bd167920
28. Bs-14600
29. Hy-109030
30. Cs-0030544
31. D11342
32. D83693
33. (2s)-2-[3-(2-chlorophenoxy)-5-oxo-2h-pyrrol-1-yl]-n-[1-[(2r)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide
34. (s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide
35. (s)-2-[4-(2-chloro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic Acid [1-((r)-2,3-dihydroxy-propyl)-1h-pyrazol-3-yl]-amide
36. 1h-pyrrole-1-acetamide, 4-(2-chlorophenoxy)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-2,5-dihydro-.alpha.-(2-methylpropyl)-2-oxo-, (.alpha.s)-
37. 1h-pyrrole-1-acetamide, 4-(2-chlorophenoxy)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-2,5-dihydro-alpha-(2-methylpropyl)-2-oxo-, (alphas)-
| Molecular Weight | 462.9 g/mol |
|---|---|
| Molecular Formula | C22H27ClN4O5 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 462.1669977 g/mol |
| Monoisotopic Mass | 462.1669977 g/mol |
| Topological Polar Surface Area | 117 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 691 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Dorzagliatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dorzagliatin, including repackagers and relabelers. The FDA regulates Dorzagliatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dorzagliatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dorzagliatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dorzagliatin supplier is an individual or a company that provides Dorzagliatin active pharmaceutical ingredient (API) or Dorzagliatin finished formulations upon request. The Dorzagliatin suppliers may include Dorzagliatin API manufacturers, exporters, distributors and traders.
click here to find a list of Dorzagliatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Dorzagliatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dorzagliatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dorzagliatin GMP manufacturer or Dorzagliatin GMP API supplier for your needs.
A Dorzagliatin CoA (Certificate of Analysis) is a formal document that attests to Dorzagliatin's compliance with Dorzagliatin specifications and serves as a tool for batch-level quality control.
Dorzagliatin CoA mostly includes findings from lab analyses of a specific batch. For each Dorzagliatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dorzagliatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dorzagliatin EP), Dorzagliatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dorzagliatin USP).
LOOKING FOR A SUPPLIER?
